Protagenic Therapeutics, Inc.\new
PTIX
Revenue
0.00
0.000.00%
3 Months ChangeAssets
1.47M
▼-1.11M▼-43.10%
3 Months ChangeLiabilities
674.56k
▲228.46k▲51.21%
3 Months ChangeFree Cash Flow
-3.85M
▼-1.86M▼-93.10%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001493152-24-042964
2024-09-18
Form 8-K
ID: 0001493152-24-036925
2024-08-14
Form 10-Q
ID: 0001493152-24-032349
2024-07-26
Form 8-K
ID: 0001493152-24-029295
2024-05-24
Form 8-K
ID: 0001493152-24-021383
2024-05-22
Form 8-K
ID: 0001493152-24-020973
2024-05-15
Form 10-Q
ID: 0001493152-24-019933
2024-03-21
Form 8-K
ID: 0001493152-24-010741
2023-12-15
Form 8-K
ID: 0001493152-23-045033
2023-11-29
Form 8-K
ID: 0001493152-23-043098